To identify the most active bioflavonoid with the properties of a TTR inhibitor and NO scavenger and to evaluate its effect in vitro and in a model of multiple sclerosis using modern information technologies (docking analysis, virtual screening program). The gene discussed is TTR; the disease is multiple sclerosis.